Table 1.
Characteristics of included studies.
| Author and year of publication | Country | Study design | Population | Type of resources reported | Resources included | Perspective |
|---|---|---|---|---|---|---|
| Buendía 2021a21 | Colombia | Budget Impact Analysis | Infants (0 to 12 months of age) |
Direct and indirect | Medical consultation at emergency room, specialist referrals, chest physiotherapy, diagnosis support, medication, medical devices, day bed in the ICU, and day bed in the general medical ward | Societal |
| Buendía 2021b22 | Colombia | Cost Effectiveness Analysis | Infants (0 to 12 months of age) |
Direct and indirect | Medical consultation at emergency room, specialist referrals, chest physiotherapy, diagnosis support, medication, medical devices, day bed in the ICU, and day bed in the general medical ward | Societal |
| Buendía 2021c25 | Colombia | Cost of Illness | Infants (0 to 12 months of age) |
Direct and indirect | Medical consultation at emergency room, specialist referrals, chest physiotherapy, diagnosis support, medication, medical devices, day bed in the ICU, and day bed in the general medical ward | Societal |
| Comas-García 202028 | Mexico | Impact study | Infants (0 to 12 months of age) |
Direct | NR | Provider perspective |
| Furlan 201623 | Brazil | Cost of Illness | Adults (20 years and older) | Direct and indirect | NR | Private Sector |
| Guevara-Cuellar 201426 | Colombia | Cost Effectiveness Analysis | Preterm infants (less than 35 weeks) or with congenital heart disease | Direct | Medications, hospitalization and consultations | Third payer |
| Jara 201924 | El Salvador y Panama | Cost of Illness | Under 10 years old | Direct and indirect | Direct medical (i.e., outpatient consultation, medications, hospital fees), non-medical (transportation, child- care), and indirect costs (lost wages) | Third payer |
| Rivera-Sepulveda 201729 | Puerto Rico | Cost of Illness | Under 18 years of age | Direct | Diagnosis and hospitalizations | Private Sector |
| Rodriguez-Martinez 202030 | Colombia | Cost of Illness | Under 2 years old | Direct | Medical and therapy services, diagnostics tests and procedures, consumables, and hospital stay | Provider perspective |
| Rodríguez‐Martínez 202231 | Colombia | Cost Effectiveness Analysis | Under 6 years old | Direct | NR | Provider perspective |
| Cintra 201327 | Brazil | Cost Effectiveness Analysis | Under 2 years old with congenital heart disease | Direct | Hospitalization in intensive care, hospitalization for treatment of pneumonia and drug (Palivizumab) | Private Sector |
| Da Silva 202232 | Brazil | Cost of Illness | Under 2 years old | Direct | NR | Private Sector |
NR, not reported.